Table 2. Plasma levels of the complement activation product SC5b-9 in DENV-infected patients.

Groups	SC5b-9 ng/mL	p-value*
Controls	128 (78.2–422.3)
DF	207.5 (143.5–316.7)
DF/WS	319.1 (234.8–482.5)	0.020@
Severe DF	389.1 (303.7–472.2)	0.040# 0.010&

*Mann–Whitney U-test.

^@DF versus DF/WS;

^#DENV-patient versus Controls;

^&Severe DF versus DF.